US Stock MarketDetailed Quotes

Arcadia Biosciences (RKDA)

Watchlist
  • 1.070
  • +0.010+0.94%
Close Apr 24 16:00 ET
2.20MMarket Cap-0.63P/E (TTM)

Arcadia Biosciences (RKDA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-3.71%4.86M
-25.90%901K
-15.29%1.3M
11.41%1.46M
21.58%1.2M
13.27%5.05M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987K
Operating revenue
-3.71%4.86M
-25.90%901K
-15.29%1.3M
11.41%1.46M
21.58%1.2M
13.27%5.05M
56.50%1.22M
18.41%1.54M
0.69%1.31M
-19.89%987K
Cost of revenue
4.56%3.1M
-14.27%709K
-14.34%884K
30.17%824K
44.80%682K
36.29%2.96M
364.61%827K
26.16%1.03M
-2.62%633K
-31.54%471K
Gross profit
-15.47%1.76M
-50.64%192K
-17.23%418K
-6.24%631K
0.39%518K
-8.68%2.08M
-35.06%389K
5.21%505K
4.02%673K
-5.15%516K
Operating expense
21.26%11.76M
-41.27%1.57M
-19.34%1.83M
145.86%6.62M
-15.96%1.74M
16.82%9.69M
56.21%2.67M
20.67%2.27M
28.18%2.69M
-53.32%2.07M
Selling and administrative expenses
-27.38%7M
-40.98%1.57M
-29.94%1.57M
-20.87%2.12M
-15.71%1.74M
17.09%9.64M
56.27%2.66M
20.35%2.24M
29.36%2.68M
-49.35%2.06M
Research and development costs
-83.02%9K
--0
--0
-10.00%9K
--0
-17.19%53K
44.44%13K
60.00%24K
-62.96%10K
-98.33%6K
Provision for doubtful accounts
--4.75M
--0
--257K
--4.49M
----
--0
--0
--0
--0
----
Operating profit
-31.31%-10M
39.67%-1.38M
19.94%-1.41M
-196.53%-5.99M
21.39%-1.22M
-26.49%-7.61M
-105.50%-2.28M
-25.98%-1.76M
-38.93%-2.02M
60.06%-1.55M
Net non-operating interest income expense
-71.74%221K
-100.28%-1K
-97.00%7K
-94.00%9K
360.00%207K
12.52%782K
125.48%354K
75.19%233K
-27.54%150K
-77.27%45K
Non-operating interest income
-71.74%221K
-100.28%-1K
-97.00%7K
-94.00%9K
360.00%207K
12.52%782K
125.48%354K
75.19%233K
-27.54%150K
-77.27%45K
Other net income (expense)
195.24%7.44M
102.28%48K
554.49%2.26M
-59.06%1.52M
545.00%3.61M
125,950.00%2.52M
-514.99%-2.1M
-44.80%345K
-15.51%3.72M
110.15%560K
Gain on sale of security
261.74%2.38M
125.88%509K
69.70%560K
-27.44%-548K
214.00%1.86M
-414.96%-1.47M
-439.72%-1.97M
-45.72%330K
-109.74%-430K
111.55%593K
Earnings from equity interest
----
----
----
----
----
----
----
----
----
--0
Special income (charges)
-30.63%2.75M
--0
--0
-75.00%1M
4,961.11%1.75M
4,819.05%3.96M
--0
--0
--4M
-289.47%-36K
-Less:Restructuring and merger&acquisition
---2M
--0
--0
---1M
---1M
--0
--0
--0
--0
--0
-Less:Impairment of capital assets
--0
--0
--0
--0
--0
-68.14%36K
--0
--0
--0
--36K
-Gain on sale of property,plant,equipment
-81.25%750K
--0
--0
--0
--750K
13,693.10%4M
--0
--0
--4M
--0
Other non- operating income (expenses)
7,348.39%2.31M
-236.50%-461K
11,220.00%1.7M
614.00%1.07M
----
108.12%31K
-1,241.67%-137K
-11.76%15K
1,253.85%150K
-90.63%3K
Income before tax
45.90%-2.33M
67.04%-1.33M
172.42%856K
-340.97%-4.46M
374.45%2.6M
19.02%-4.31M
-805.39%-4.03M
-84.98%-1.18M
-41.38%1.85M
89.71%-947K
Income tax
0.00%8K
0.00%8K
14.29%8K
0
0
Net income
66.77%-2.34M
67.13%-1.34M
153.10%856K
-520.17%-4.46M
207.26%2.6M
49.68%-7.04M
-42.45%-4.06M
37.20%-1.61M
29.71%1.06M
74.18%-2.42M
Net income continuous Operations
45.82%-2.34M
66.91%-1.34M
172.42%856K
-340.97%-4.46M
374.45%2.6M
18.99%-4.32M
-793.14%-4.04M
-84.98%-1.18M
-41.36%1.85M
89.71%-947K
Net income discontinuous operations
--0
--0
--0
--0
--0
68.57%-2.72M
98.88%-27K
77.70%-430K
66.24%-789K
-715.47%-1.48M
Minority interest income
0
0
0
0
Net income attributable to the parent company
66.77%-2.34M
67.13%-1.34M
153.10%856K
-520.17%-4.46M
207.26%2.6M
49.66%-7.04M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
66.77%-2.34M
67.13%-1.34M
153.10%856K
-520.17%-4.46M
207.26%2.6M
49.66%-7.04M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
Basic earnings per share
66.92%-1.71
67.22%-0.98
153.39%0.63
-517.95%-3.26
206.74%1.9
54.21%-5.17
-51.01%-2.99
37.57%-1.18
27.87%0.78
83.61%-1.78
Diluted earnings per share
66.92%-1.71
67.22%-0.98
152.54%0.62
-517.95%-3.26
206.74%1.9
54.21%-5.17
-51.01%-2.99
37.57%-1.18
27.87%0.78
83.61%-1.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -3.71%4.86M-25.90%901K-15.29%1.3M11.41%1.46M21.58%1.2M13.27%5.05M56.50%1.22M18.41%1.54M0.69%1.31M-19.89%987K
Operating revenue -3.71%4.86M-25.90%901K-15.29%1.3M11.41%1.46M21.58%1.2M13.27%5.05M56.50%1.22M18.41%1.54M0.69%1.31M-19.89%987K
Cost of revenue 4.56%3.1M-14.27%709K-14.34%884K30.17%824K44.80%682K36.29%2.96M364.61%827K26.16%1.03M-2.62%633K-31.54%471K
Gross profit -15.47%1.76M-50.64%192K-17.23%418K-6.24%631K0.39%518K-8.68%2.08M-35.06%389K5.21%505K4.02%673K-5.15%516K
Operating expense 21.26%11.76M-41.27%1.57M-19.34%1.83M145.86%6.62M-15.96%1.74M16.82%9.69M56.21%2.67M20.67%2.27M28.18%2.69M-53.32%2.07M
Selling and administrative expenses -27.38%7M-40.98%1.57M-29.94%1.57M-20.87%2.12M-15.71%1.74M17.09%9.64M56.27%2.66M20.35%2.24M29.36%2.68M-49.35%2.06M
Research and development costs -83.02%9K--0--0-10.00%9K--0-17.19%53K44.44%13K60.00%24K-62.96%10K-98.33%6K
Provision for doubtful accounts --4.75M--0--257K--4.49M------0--0--0--0----
Operating profit -31.31%-10M39.67%-1.38M19.94%-1.41M-196.53%-5.99M21.39%-1.22M-26.49%-7.61M-105.50%-2.28M-25.98%-1.76M-38.93%-2.02M60.06%-1.55M
Net non-operating interest income expense -71.74%221K-100.28%-1K-97.00%7K-94.00%9K360.00%207K12.52%782K125.48%354K75.19%233K-27.54%150K-77.27%45K
Non-operating interest income -71.74%221K-100.28%-1K-97.00%7K-94.00%9K360.00%207K12.52%782K125.48%354K75.19%233K-27.54%150K-77.27%45K
Other net income (expense) 195.24%7.44M102.28%48K554.49%2.26M-59.06%1.52M545.00%3.61M125,950.00%2.52M-514.99%-2.1M-44.80%345K-15.51%3.72M110.15%560K
Gain on sale of security 261.74%2.38M125.88%509K69.70%560K-27.44%-548K214.00%1.86M-414.96%-1.47M-439.72%-1.97M-45.72%330K-109.74%-430K111.55%593K
Earnings from equity interest --------------------------------------0
Special income (charges) -30.63%2.75M--0--0-75.00%1M4,961.11%1.75M4,819.05%3.96M--0--0--4M-289.47%-36K
-Less:Restructuring and merger&acquisition ---2M--0--0---1M---1M--0--0--0--0--0
-Less:Impairment of capital assets --0--0--0--0--0-68.14%36K--0--0--0--36K
-Gain on sale of property,plant,equipment -81.25%750K--0--0--0--750K13,693.10%4M--0--0--4M--0
Other non- operating income (expenses) 7,348.39%2.31M-236.50%-461K11,220.00%1.7M614.00%1.07M----108.12%31K-1,241.67%-137K-11.76%15K1,253.85%150K-90.63%3K
Income before tax 45.90%-2.33M67.04%-1.33M172.42%856K-340.97%-4.46M374.45%2.6M19.02%-4.31M-805.39%-4.03M-84.98%-1.18M-41.38%1.85M89.71%-947K
Income tax 0.00%8K0.00%8K14.29%8K00
Net income 66.77%-2.34M67.13%-1.34M153.10%856K-520.17%-4.46M207.26%2.6M49.68%-7.04M-42.45%-4.06M37.20%-1.61M29.71%1.06M74.18%-2.42M
Net income continuous Operations 45.82%-2.34M66.91%-1.34M172.42%856K-340.97%-4.46M374.45%2.6M18.99%-4.32M-793.14%-4.04M-84.98%-1.18M-41.36%1.85M89.71%-947K
Net income discontinuous operations --0--0--0--0--068.57%-2.72M98.88%-27K77.70%-430K66.24%-789K-715.47%-1.48M
Minority interest income 0000
Net income attributable to the parent company 66.77%-2.34M67.13%-1.34M153.10%856K-520.17%-4.46M207.26%2.6M49.66%-7.04M-42.45%-4.06M37.20%-1.61M28.92%1.06M74.18%-2.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 66.77%-2.34M67.13%-1.34M153.10%856K-520.17%-4.46M207.26%2.6M49.66%-7.04M-42.45%-4.06M37.20%-1.61M28.92%1.06M74.18%-2.42M
Basic earnings per share 66.92%-1.7167.22%-0.98153.39%0.63-517.95%-3.26206.74%1.954.21%-5.17-51.01%-2.9937.57%-1.1827.87%0.7883.61%-1.78
Diluted earnings per share 66.92%-1.7167.22%-0.98152.54%0.62-517.95%-3.26206.74%1.954.21%-5.17-51.01%-2.9937.57%-1.1827.87%0.7883.61%-1.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More